We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
-3.52%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$7.69B
AUM Growth
-$448M
Cap. Flow
-$70.5M
Cap. Flow %
-0.92%
Top 10 Hldgs %
44.95%
Holding
656
New
10
Increased
46
Reduced
188
Closed
44

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$7.99M
2
WEX icon
WEX
WEX
+$6.04M
3
ALGN icon
Align Technology
ALGN
+$5.99M
4
TMO icon
Thermo Fisher Scientific
TMO
+$4.36M
5
BR icon
Broadridge
BR
+$4.23M

Sector Composition

Rank Sector Weight
1 Technology 34.09%
2 Healthcare 20.74%
3 Financials 10.64%
4 Consumer Discretionary 10.37%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WASH icon
426
Washington Trust Bancorp
WASH
$766M
$43K ﹤0.01%
919
AVAV icon
427
AeroVironment
AVAV
$9.54B
$42K ﹤0.01%
500
BNY
428
Bank of New York Mellon
BNY
$110B
$42K ﹤0.01%
1,100
EA
429
DELISTED
Electronic Arts
EA
$42K ﹤0.01%
359
KIM icon
430
Kimco Realty
KIM
$16.3B
$42K ﹤0.01%
2,301
RSKD icon
431
Riskified
RSKD
$835M
$42K ﹤0.01%
10,707
THG icon
432
Hanover Insurance
THG
$7.73B
$42K ﹤0.01%
325
VTRS icon
433
Viatris
VTRS
$18.7B
$42K ﹤0.01%
4,928
-31
-0.6% -$305
ZBH icon
434
Zimmer Biomet
ZBH
$18.7B
$42K ﹤0.01%
399
AMP icon
435
Ameriprise Financial
AMP
$50B
$41K ﹤0.01%
162
ASHR icon
436
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
$41K ﹤0.01%
+1,527
New +$46.8K
CRSP icon
437
CRISPR Therapeutics
CRSP
$5.22B
$41K ﹤0.01%
635
IFF icon
438
International Flavors & Fragrances
IFF
$21.5B
$41K ﹤0.01%
454
KMX icon
439
CarMax
KMX
$8.41B
$41K ﹤0.01%
625
-1,505
-71% -$138K
PAGS icon
440
PagSeguro Digital
PAGS
$2.42B
$40K ﹤0.01%
3,005
IRBT
441
DELISTED
iRobot
IRBT
$39K ﹤0.01%
700
O icon
442
Realty Income
O
$59.8B
$39K ﹤0.01%
666
BNS icon
443
Scotiabank
BNS
$110B
$38K ﹤0.01%
800
SCHF icon
444
Schwab International Equity ETF
SCHF
$69.4B
$38K ﹤0.01%
2,720
CATC
445
DELISTED
CAMBRIDGE BANCORP
CATC
$38K ﹤0.01%
480
MTRN icon
446
Materion
MTRN
$5.98B
$37K ﹤0.01%
457
PNW icon
447
Pinnacle West Capital
PNW
$12.2B
$37K ﹤0.01%
567
VLO icon
448
Valero Energy
VLO
$97.2B
$37K ﹤0.01%
350
-75
-18% -$8.25K
CBSH icon
449
Commerce Bancshares
CBSH
$8.61B
$36K ﹤0.01%
666
DVY icon
450
iShares Select Dividend ETF
DVY
$23.9B
$36K ﹤0.01%
334
-109
-25% -$13.1K

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Loring Wolcott & Coolidge Fiduciary Advisors held 656 positions worth $7.69B, down 5.5% from $8.14B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q3 2022 filing shows 10 new, 46 increased, 188 reduced and 44 closed positions. Its largest new stake was iShares Expanded Tech-Software Sector ETF: 11,900 shares worth $595K. The largest sale was Hannon Armstrong Sustainable Infrastructure Capital, an estimated $25.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q3 2022 buy was iShares Expanded Tech-Software Sector ETF: 11,900 shares worth $595K.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to NVIDIA in Q3 2022, an estimated $7.99M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q3 2022 reduction was Hannon Armstrong Sustainable Infrastructure Capital, cutting an estimated $25.1M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $2.07M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 45% of its $7.69B portfolio in Q3 2022.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 10 new positions and closed 44 in Q3 2022.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 5.5% quarter-over-quarter to $7.69B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2022, filed 25 Oct 2022.